Recent studies demonstrated that Nrf2 was essential in the prevention of high glucose-induced oxidative damage in cardiomyocytes, endothelial cells and vascular smooth muscle cells [28–30], and in animal models of DCM [31]. This evidence concerns the gene NFE2L2 and familial dilated cardiomyopathy.